Xylocaine Report

Byerly, W. (2009). Working with the institutional review board. American Journal of Health-System Pharmacy: AJHP: Official Journal Of The American Society Of Health System Pharmacists, 66(2), 176-184. Retrieved from http://library.kaplan.edu/content.php?pid=150035

(He says that because Stan is on Ratio-Oxycocet, he should not take both that and Lenoltec 1 at the same time, as there are drug interactions including the 8mg codeine as well as the acetaminophen in Lenoltec 1. The codeine can increase seizures from occurring when combined with Ratio-Oxycocet, and there is 300mg acetaminophen in Lenoltec 1 as well, which would double a patient’s dose of it, which could become toxic to a body. They are in the same drug classes as the Ratio-Oxycocet as well, being antipyretics and analgesics. The indication for use is similar, as it is used to relieve mild to moderate pain. Contraindications include sensitivity to the active drugs, bowel obstructions, respiratory issues such as bronchial asthma, alcoholism, depression etc. Warnings include addiction, misuse and tampering before consumption resulting in life threatening events. Side effects are like those of opioid analgesics, such as drowsiness, light-headedness, dizziness, sedation, shortness of breath, nausea, and vomiting which can be reduced if patient lays

Toxic doses of lidocaine can cause seizures and respiratory arrest. Furthermore, whenever lidocaine is used, equipment for cardiopulmonary resuscitation must be available for use.

The Joint Commission is a not-for –profit organization. It’s a private nongovernmental program that is purposed for improving the quality of health care. The Joint Commission accredits more than 21,000 health care organizations in the United States. This document has created a standard and national patient safety goal in which health care providers must comply. A list was created do to the fact that many error has been made throughout the medical system. The Joint Commission brought forth, which is known as the do-not-use-list. This list contain many errors of words been misuse when it comes down to the medical field. When dealing with medication it’s very easy to make a mistake by a hand written prescription cause by rush handing writing

According to pharmacist T. Perryman, the errors he sees the most in the pharmacy setting “occurs when hospital made barcodes are being added to the medication rather than the medication having factory barcodes already present.” The process of standardizing all pharmaceutical drug

The intravenous dosage in this case is 0.5 - 1 mg/kg IV (range: 0.5 - 2 mg/kg).

There are over 95,000 labels and warnings on drugs and medical devices that people and animal consume and use today, under the regulation of the FDA

High Alllert Medications (HAMs) are a special class of drugs that are highly risky and capable of causing harm even under proper use. Consequently, they necessitate the need for Independent Double-Checks (IDC). As such, the nurse verifies the dosage, drug, and route to match the directives of the physician as well as pharmacological requirements (Galbraith et al., 2015). Such drugs include sedatives, opioids, insulin and anticoagulants. IDC minimizes errors asserted to drug name confusion such as heparin/Hespan; lack of knowledge, and confusion from interruption or fatigue. My colleagues implement IDC in spite of the constraints experienced. However, some rare incidences of workarounds occur during weekends or emergencies when no verifier is

It, therefore, implies that when a person gets the wrong name of the prescription drug, it means that the patient will not receive the required treatment. The other reason why we should have increased awareness on SALAD medications is that some of these drugs contain ephedra, caffeine, and phenylpropanolamine and people who have used the drugs containing these compounds have developed convulsions and fell into comas (Goldberg, 2013). In some extreme cases, the patient may develop complications which were not present before. Next, the customers should be able to minimize the risk of getting wrong medications. Also, the consumers can be aware of a particular drug that is administered and the proper use of the drug. The consumers can be able to confirm if the physician has clearly written the drug’s name by trying to read

As of October 2, 2017 there has been a reverified shortage of the Lidocaine Hydrochloride injection. The generic name is Lidocaine where the brand name is Xylocaine. It is a Local Anesthetic and an Antiarrhythmic Agent Class 1b. Xylocaine is used as a local anesthetic by infiltration, epidural or nerve block; and it also used to treat ventricular arrhythmias from myocardial infarction.

Not only does the electronic method of prescribing save time, it has also cut down on the number of accidents caused by the misinterpretation of handwriting. Although now almost obsolete, hand-written prescriptions have been the cause of many medical errors because certain sound-alike or look-alike drugs have, in the past, been incorrectly substituted for one another. A report given by the insurance company, Excellus BlueCross BlueShield disclosed that if all physicians were to begin using electronic-prescription systems, “more than two million adverse reactions or events – ranging from inconsequential to severe – could be avoided each year” (wgrz.com). According to pharmacist and associate director for the Food and Drug Administration’s Office of Drug Safety, Jerry Phillips, “Six-hundred sound-alike or look-alike drug pairs have been identified as possible sources of error since 1992” (nytimes.com). For example, Lamictal, a mood-stabilizing anticonvulsant, is quite similar in spelling to Lamisil, an antifungal drug. Because of these strong similarities, it is not difficult to understand how easy it could be for medical personnel to mistake certain medications. But with e-prescribing, because the prescription is sent directly from the prescriber to the pharmacy, the number of accidents caused by misinterpretation of handwriting has already been

Food and Drug Administration is warning health care professionals and patients that reports of confusion between Brintellix and Brillinta have resulted in the wrong medication being prescribed or dispensed (FDA, 2015). The main reason for confusion is the similarity in their brand names. As of June 2015, FDA has received 50 reports of medication error cases. The reports point out error in prescribing and dispensing, none of the reports indicated that the patient ingested wrong medicine (FDA, 2015). The report shows greater concern in the similarities in the way both of the medication sound, look and can cause greater confusion for prescribers and pharmacists. Even in one case, a pharmacist misinterpreted Brintellix as Brillinta, but luckily didn’t dispense the medicine as the patient had contraindication to blood thinners (FDA, 2015). FDA recommends both health care professionals and patients to report name confusion and medication errors that include Brintellix and Brillinta to the FDA MedWatch

Xylitol is a polyol derived from xylose (Santos et al., 2015).It was discovered in the late19thcentury. Xylitol is likewise normally found in low concentrations in a variety of edible plants and mushrooms (Peterson, 2013).

inflamatory agent like DMSO. Hot packings of the affected area with clean towel are also helpful. If it occurrs due to indwelling catheters, etc., it should be removed immediately. If infection is suspected, than enrofloxacin, chloremphenicol, doxycyclin and potentited sulpha drungs are preferred. Drainage is indicated if large fluid pocket is located below skin (Harold and McKenzie, 2009; Dias and Neto, 2013) If the thrombotic lesion is associated with a generalized coagulopathy, heparin therapy @ 40 to 100 IU/kg body weight, i.v.or s.c. should be given on every six hours interval (Orsini andDivers, 2008).Aspirin at a dose of 20 mL/kg body weight every other day is also recommended for the treatment of thrombophlebitis to inhibit platelet

Food and Drug Administration have inferred, and ideally will suggest a few changes to lessen the perplexity. The Institute For Safe Medication Practices and FDA have inquired pharmaceutical manufacturers of often puzzling and confusing drug pairs to alter the labels and handling by utilizing “tall man” letters and distinctive colors in